Hirokazu Kanegane

Phenotype, penetrance, and treatment of 133 cytotoxic T-lymphocyte antigen 4–insufficient subjects

Charlotte Schwab, Annemarie Gabrysch, Peter Olbrich et al. · Journal of Allergy and Clinical Immunology · 2018 · 441 citations · Full text

Life Sciences, Immunology, Pharmacology +12

Clinical and virologic characteristics of chronic active Epstein-Barr virus infection

Hiroshi Kimura, Yo Hoshino, Hirokazu Kanegane et al. · Blood · 2001 · 426 citations · Full text

Life Sciences, Immunology, Infectious Diseases +14

The landscape of somatic mutations in Down syndrome–related myeloid disorders

Kenichi Yoshida, Tsutomu Toki, Yusuke Okuno et al. · Nature Genetics · 2013 · 387 citations

Life Sciences, Genetics, Molecular Genetics +15

Clinical similarities and differences of patients with X-linked lymphoproliferative syndrome type 1 (XLP-1/SAP deficiency) versus type 2 (XLP-2/XIAP deficiency)

Jana Pachlopnik Schmid, Danielle Canioni, Despina Moshous et al. · Blood · 2010 · 366 citations · Full text

Life Sciences, Genetics, Hematology +8

X-linked lymphoproliferative disease due to SAP/SH2D1A deficiency: a multicenter study on the manifestations, management and outcome of the disease

Claire Booth, Kimberly Gilmour, Paul Veys et al. · Blood · 2010 · 319 citations · Full text

Life Sciences, Hematology, Immunology +9